February 15, 2018 / 2:15 PM / 6 months ago

BRIEF-Precipio Launches Unique Lung Cancer Monitoring Test For Therapy Resistance

Feb 15 (Reuters) - Precipio Inc:

* PRECIPIO LAUNCHES UNIQUE LUNG CANCER MONITORING TEST FOR THERAPY RESISTANCE

* PRECIPIO INC - LAUNCHES FIRST LUNG CANCER TREATMENT RESISTANCE PANEL SPECIFICALLY FOR CRITICAL MUTATIONS T790M AND C797S IN EGFR GENE

* PRECIPIO INC - LUNG CANCER TREATMENT RESISTANCE PANEL IS BILLED AT BELOW $500 FOR BOTH T790M AND C797S MUTATIONS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below